This is the last of the three-part podcast series, Keeping up with the Chemos on Lenvatinib/pembrolizumab.  Our multidisciplinary panel will discuss the challenges with patient monitoring while on Lenvatinib/pembrolizumab.  The panel discusses personal clinical experiences and lessons learned.  When to dose adjust and hold or even discontinue Lenvatinib/pembrolizumab. Once again, the session ends with take home points for patient monitoring while on Lenvatinib/pembrolizumab.  

2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ

Speakers:
Jennifer MacDonald, Pharm.D, BCOP
Pamela Soliman, MD